Advertisement

Fibrin Formation: Implications for Tumor Growth and Metastasis

  • Harold F. Dvorak
  • Donald R. Senger
  • Ann M. Dvorak
Chapter
Part of the Developments in Oncology book series (DION, volume 22)

Abstract

Whether undertaken by pathologists, immunologist, or biochemists, studies of tumor biology have traditionally concentrated on the malignant cells themselves, their abnormal morphology, their altered metabolism and more recently, their panoply of surface antigens. Yet, tumors are comprised not only of malignant cells but also of stroma. In the case of many solid tumors stroma may actually comprise the bulk of the mass perceived as tumor with the naked eye. In any event, tumors are dependent on stroma for nutrient supply and removal of metabolic wastes. Tumor stroma is not a homogeneous entity but rather consists of several connective tissue elements including collagen of several types, elastin, fibronectin, glycosaminoglycans, interstitial fluid, new blood vessels and, as we shall discuss in this chapter, fibrin.

Keywords

Tissue Factor Tumor Vesicle Fibrin Deposit Fibrous Connective Tissue Procoagulant Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Trousseau A. Clinique Medicale de l’Hotel-dieu de Paris. J.B. Bailliere et Fils, , 5th Edition. 3: 94, 1865.Google Scholar
  2. 2.
    O’Meara RAQ and Jackson RD. Ir. J. Med. Sci. 6: 327–328, 1958.Google Scholar
  3. 3.
    O’Meara RAQ. Ir. J. Med. Sci. 6: 474–479, 1958.Google Scholar
  4. 4.
    Gitlin D and Craig JM. Am. J. Pathol. 33: 267–283, 1957.PubMedGoogle Scholar
  5. 5.
    Day ED, Planinsek JA and Pressman D. J. Natl. Cancer Inst. 22: 413–426, 1959.PubMedGoogle Scholar
  6. 6.
    Marrack D, Kubala M, Corry P, Leavens M, Howze J, Dewey W, Bale WF and Spar IL. Cancer (Philadelphia) 20: 751–755, 1967.CrossRefGoogle Scholar
  7. 7.
    Hiramoto R, Yagi Y and Pressman D. Cancer Res. 19: 874–879, 1959.PubMedGoogle Scholar
  8. 8.
    Hiramoto R, Bernecky J, Jurandowski J and Pressman D. Cancer Res. 20:592–593, 1960.Google Scholar
  9. 9.
    Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ, Forcier RJ, Harrower HW and Johnson RO. Cancer (Philadelphia) 44: 732–741, 1979.CrossRefGoogle Scholar
  10. 10.
    Donati MB, Davidson JF and Garattini S, eds. Malignancy and the Hemostatic System. Raven Press, New York, 1981.Google Scholar
  11. 11.
    Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ, Forcier RJ, Edwards R, Headley E, Kim S-H, O’Donnell JR, O’Dell R, Tornyos K and Kwaan HC. J. Am. Med. Assoc. 245: 831–835, 1981.CrossRefGoogle Scholar
  12. 12.
    Chan S-Y and Pollard M J. Natl. Cancer Inst. 64: 1121–1125, 1980.PubMedGoogle Scholar
  13. 13.
    Chew EC and Wallace AC. Cancer Res. 36: 1904–1909, 1976.PubMedGoogle Scholar
  14. 14.
    Wood S, Holyoke ED and Yardley JH. Proc. Can. Cancer Res. Conf. 4: 167–221, 1961.Google Scholar
  15. 15.
    Kinjo M. Br. J. Cancer 38: 293–300, 1978.PubMedCrossRefGoogle Scholar
  16. 16.
    Maat B. Br. J. Cancer 37: 369–376, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Vaheri A and Mosher DF. Biochim. Biophys. Acta. 516: 1–25, 1978.PubMedGoogle Scholar
  18. 18.
    Nossel HL. N. Engl. J. Med. 295: 428–432, 1981.Google Scholar
  19. 19.
    Davie EW, Fujikawa K, Kurachi K and Kisiel W. Adv. Enzymol. 48: 277–318, 1979.PubMedGoogle Scholar
  20. 20.
    Folk JE and Finlayson JS. Adv. Protein Chem. 31: 1–133, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    Hermans J and McDonagh J. Semin. Thromb. Hemostasis 8: 11–24, 1982.CrossRefGoogle Scholar
  22. 22.
    Robbins KC, Wohl RC and Summaria L. Ann. N.Y. Acad. Sci. 37: 588–591, 1981.CrossRefGoogle Scholar
  23. 23.
    Reich E. In: Proteases and Biological Control. (Eds. Reich E, Rifkin DB and Shaw E), Cold Spring Harbor, New York, pp. 333–341, 1975.Google Scholar
  24. 24.
    Wiman B and Collen D. Nature (London) 272: 549–550, 1978.CrossRefGoogle Scholar
  25. 25.
    Marder VJ and Budzynski AZ. Thromb. Diath. Haemorrh. 33: 199–207, 1975.Google Scholar
  26. 26.
    Osbahr AJ, Gladner JA and Laki K. Biochim. Biophys. Acta 86: 535–542, 1964.PubMedGoogle Scholar
  27. 27.
    Stecher VJ and Sorkin E. Int. Arch. Allergy Appl. Immunol. 43: 879–886, 1972.PubMedCrossRefGoogle Scholar
  28. 28.
    Kay AB, Pepper DS and Ewart MR. Nature (London) New Biol. 243: 56–57, 1973.CrossRefGoogle Scholar
  29. 29.
    Girmann G, Pees H, Schwarze G and Scheurlen PG. Nature (London) 259: 399–401, 1976.CrossRefGoogle Scholar
  30. 30.
    Richardson DL, Pepper DS and Kay AB. Br. J. Haematol. 32: 507–513, 1976.PubMedCrossRefGoogle Scholar
  31. 31.
    Belew M, Gerdin B, Porath J and Saldeen T. Thromb. Res. 13: 983–994, 1978.PubMedCrossRefGoogle Scholar
  32. 32.
    Gerdin B and Saldeen T. Thromb. Res. 13: 995–1006, 1978.PubMedCrossRefGoogle Scholar
  33. 33.
    Krzystyniak K, Stachurska J, Ryzewski J, Bykowska K and Kopec M. Thromb. Res. 12: 523–530, 1978.PubMedCrossRefGoogle Scholar
  34. 34.
    Belew M, Gerdin B, Lindeberg G, Porath J, Saldeen T and Wallin R. Biochim. Biophys. Acta 621: 169–178, 1980.Google Scholar
  35. 35.
    Plow EF, Freaney D and Edgington TS. J. Immunol. 128: 1595–1599, 1982.PubMedGoogle Scholar
  36. 36.
    Francis CW, Marder VJ and Barlow GH. J. Clin. Invest. 66: 1033–1043, 1980.PubMedCrossRefGoogle Scholar
  37. 37.
    Colvin RB and Dvorak HF. J. Inmunol. 114: 377–387, 1975.Google Scholar
  38. 38.
    Dvorak HF, Galli SJ and Dvorak AM. Int. Rev. Exp. Pathol. 21: 119–194, 1980.PubMedGoogle Scholar
  39. 39.
    Churchill WH Jr., Rapp HJ, Kronman BS and Borsos T. J. Natl. Cancer Inst. 41: 13–29, 1968.Google Scholar
  40. 40.
    Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L and Churchill WH. J. Natl. Cancer Inst. 62: 1459–1472, 1979.PubMedGoogle Scholar
  41. 41.
    Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J and Giovinco P. J. Immunol. 122: 166–174, 1979.PubMedGoogle Scholar
  42. 42.
    Dvorak HF, Dickersin GR, Dvorak AM, Manseau EJ and Pyne K. J. Natl. Cancer Inst. 67: 335–345, 1981.PubMedGoogle Scholar
  43. 43.
    Harris NL, Dvorak AM, Smith J and Dvorak HF. Am. J. Pathol. 108: 119–129, 1982.Google Scholar
  44. 44.
    Cooper JH, Haq M and Bagnell H. J. Pathol. 98: 193–199, 1969.PubMedCrossRefGoogle Scholar
  45. 45.
    Dvorak HF, Mihm MC Jr., Dvorak AM, Barnes BA, Manseau EJ and Galli SJ. J. Exp. Med. 150: 322–337, 1979.PubMedCrossRefGoogle Scholar
  46. 46.
    Dvorak HF, Orenstein NS and Dvorak AM. Lymphokines 2: 203–233, 1981.Google Scholar
  47. 47.
    Dvorak HF, Senger DR and Dvorak AM. Cancer Metastasis Rev., in press, 1983.Google Scholar
  48. 48.
    Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41: 964, 1982.Google Scholar
  49. 49.
    Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF. Science 219: 983–985, 1983.PubMedCrossRefGoogle Scholar
  50. 50.
    Gordon SG and Cross BA J. Clin. Invest. 67: 1665–1671, 1981.PubMedCrossRefGoogle Scholar
  51. 51.
    Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Yahata Y and Yasuiroto K. Br. J. Cancer 39: 15–23, 1979.PubMedCrossRefGoogle Scholar
  52. 52.
    Laki K, Tyler HM and Yancey ST. Biochem. Biophys. Res. Comiiun. 24: 776–781, 1966.CrossRefGoogle Scholar
  53. 53.
    Zacharski LR and Mclntyre OR. J. Med. 4: 118–131, 1973.Google Scholar
  54. 54.
    Green D, Ryan C, Malandruccolo N and Nadler HL. Blood 37: 47–51, 1971.PubMedGoogle Scholar
  55. 55.
    Maynard JR, Fintel DJ, Pitlick FA and Nerasrson Y. Lab. Invest. 35: 542–549, 1976.PubMedGoogle Scholar
  56. 56.
    Khato J, Suzuki M and Sato H. Gann 65: 289–294, 1974.PubMedGoogle Scholar
  57. 57.
    Cattan A and Bresson ML. Biomedicine 25: 252–254, 1976.PubMedGoogle Scholar
  58. 58.
    Curatolo L, Colucci M, Cambini AL, Poggi A, Morasca L, Donati MB and Semeraro N. Br. J. Cancer 40: 228–233, 1979.PubMedCrossRefGoogle Scholar
  59. 59.
    Folkman J. Adv. Cancer Res. 19: 331–358, 1974.PubMedCrossRefGoogle Scholar
  60. 60.
    Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM and Carvalho AC. Science 212: 923–924, 1981.PubMedCrossRefGoogle Scholar
  61. 61.
    Dvorak HF, Van De Water L, Dvorak AM, Harvey VS, Anderson D, DeWolf W and Bach R. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41: 8, 1982.Google Scholar
  62. 62.
    Gordon SG and Lewis B. J. Cancer Res. 38: 2467–2472, 1978.Google Scholar
  63. 63.
    Nemerson Y, Zur M, Bach R and Gentry R. In: The Regulation of Coagulation. (Eds. Mann KG and Taylor FB), Elsevier/North Holland, New York, pp. 193–202, 1980.Google Scholar
  64. 64.
    Bach R, Nemerson Y and Konigsberg W. J. Biol. Chem. 256: 8324–8331, 1981.PubMedGoogle Scholar
  65. 65.
    Maynard JR, Heckman CA, Pitlick FA and Nemerson Y. J. Clin. Invest. 55: 814–824, 1975.PubMedCrossRefGoogle Scholar
  66. 66.
    Maynard JR, Dreyer BE, Stemerman MB and Pitlick FA. Blood 50: 387–396, 1977.PubMedGoogle Scholar
  67. 67.
    Pineo GF, Brain MC, Gallus AS, Hirsh J, Hatton MWC and Regoeczi E. Ann. N.Y. Acad. Sci. 230: 262–270, 1974.PubMedCrossRefGoogle Scholar
  68. 68.
    Gordon SG. J. Histochem. Cytochem. 29: 457–463, 1981.PubMedCrossRefGoogle Scholar
  69. 69.
    Black PH. Adv. Cancer Res. 32: 75–199, 1980.PubMedCrossRefGoogle Scholar
  70. 70.
    Doljanski F and Kapeller M. J. Theor. Biol. 62: 253–270, 1976.PubMedCrossRefGoogle Scholar
  71. 71.
    Calafat J, Hilgers J, Van Blitterswijk WJ, Verbeet M and Hageman PC. J. Natl. Cancer Inst. 56: 1019–1029, 1976.PubMedGoogle Scholar
  72. 72.
    Koch GLE and Smith MJ. Nature (London) 273: 274–277, 1978.CrossRefGoogle Scholar
  73. 73.
    Raz A, Goldman R, Yuli I and Inbar M. Cancer Immunol. Immunother. 4: 5. 4: 53–59, 1978.CrossRefGoogle Scholar
  74. 74.
    Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB and Stewart GJ. Cancer Res. 38: 2950–2955, 1978.PubMedGoogle Scholar
  75. 75.
    Bitzer AM, Carvalho ACA, Davis GL and Dvorak HF. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41: 7880, 1981.Google Scholar
  76. 76.
    Dvorak HF, Van De Water L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, DeWolf W and Carvalho ACA. Submitted.Google Scholar
  77. 77.
    Dunkel VC, Bast RC, Gerwin BI, Heine V, Cotter-Fox M and Borsos T. J. Natl. Cancer Inst. 53: 591–593, 1974.PubMedGoogle Scholar
  78. 78.
    Laki K, Tyler HM and Yancey ST. Biochem. Biophy. Res. Commun. 24: 776–781, 1966.CrossRefGoogle Scholar
  79. 79.
    Ratrioff OD. Adv. Inminol. 10: 145–227, 1969.CrossRefGoogle Scholar
  80. 80.
    Colman RW, Osbahr AJ and Morris RE. Nature (London) 215: 292–293, 1967.CrossRefGoogle Scholar
  81. 81.
    Glenn KC, Carney DH, Fenton JW II and Cunningham DD. J. Biol. Chem. 255: 6609–6616, 1980.PubMedGoogle Scholar
  82. 82.
    Postlethwaite AE, Keski-Oja J, Balian G and Kang AH. J. Exp. Med. 153: 494–499, 1981.PubMedCrossRefGoogle Scholar
  83. 83.
    Tsukamoto Y, Helsel WE and Wahl SM. J. Immunol. 127: 673–678, 1981.PubMedGoogle Scholar
  84. 84.
    Clark RAF, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF and Colvin RB. J. Invest. Dermatol. 79: 264–269, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Harold F. Dvorak
  • Donald R. Senger
  • Ann M. Dvorak

There are no affiliations available

Personalised recommendations